Home
Scribe Therapeutics, Inc.

Scribe Therapeutics, Inc. Market Share Analysis for March 2026

We’re unlocking the future of medicine with CRISPR-based therapeutics that are safe and effective enough to transform everyone's lifetime risk for disease.

Health > Biotechnology and Pharmaceuticals

Domainscribetx.com

Year Founded2017

Employees51 - 200

Annual Revenue$2M - $5M

Scribe Therapeutics, Inc.

Scribe Therapeutics, Inc. (including company regionals)

scribetx.com

See more website traffic and engagement information

Scribe Therapeutics, Inc. Revenue up to March 2026 is 2M - 5M

revenue generated by Scribe Therapeutics, Inc. top domains

Scribe Therapeutics, Inc. top domains revenue over 3 years

Revenue for Scribe Therapeutics, Inc. top domains

scribetx.com2M - 5M

See more with Sales Intelligence

Total visits to Scribe Therapeutics, Inc.'s top domains

Understand Scribe Therapeutics, Inc. market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

scribetx.com8.9K

See more with Sales Intelligence

Avg. visit duration in Scribe Therapeutics, Inc.'s top domains

Analyze Scribe Therapeutics, Inc. engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

scribetx.com00:00:27

See more with Sales Intelligence

Avg. pageviews on Scribe Therapeutics, Inc.'s top domains

See how Scribe Therapeutics, Inc. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

scribetx.com1.56

See more with Sales Intelligence

Scribe Therapeutics, Inc. top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Scribe Therapeutics, Inc.

These are the website technologies, by industry, used by Scribe Therapeutics, Inc. top domains

Advertising (3)

Google Adsense

Audio Video Media (3)

YouTube

Content Management System (3)

WordPress

Email Services (3)

G Suite

More Technologies

8

See all

News & Signals from Scribe Therapeutics, Inc.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsKhakoo leaves Scribe as chief scientific officer and head of research and development.Dr. Khakoo joins Generate from Scribe Therapeutics, where he served as chief scientific officer and head of research and development, leading platform development, biology discovery, and translational research for a next-generation genome editing and epigenetic silencing platform.

NewsScribe is developing medicines based on novel CRISPR enzymes on Jul 1st '17.Scribe Therapeutics, founded almost nine years ago to develop medicines based on novel CRISPR enzymes, is getting ready to test its first therapy in the...

NewsScribe attends event 44th Annual J.P. Morgan Healthcare Conference.Scribe Therapeutics to present at the 44th Annual J.P. Morgan Healthcare Conference.